secwatch / observer
8-K filed August 2, 2023, 7:59 PM ET ticker IDXG CIK 0001054102
leadership confidence high sentiment neutral materiality 0.50

Interpace Biosciences appoints Christopher McCarthy as CFO effective July 24, 2023

INTERPACE BIOSCIENCES, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Christopher McCarthy

Chief Financial Officer
IDXG · INTERPACE BIOSCIENCES, INC.
Effective
2023-07-24
Filed
August 2, 2023, 7:59 PM ET
On July 24, 2023, the Board of Directors (the “ Board ”) of Interpace Biosciences, Inc. (the “ Company ”) appointed Christopher McCarthy, age 32, as Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher McCarthy was appointed as Chief Financial Officer at INTERPACE BIOSCIENCES, INC..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
On July 24, 2023, the Board of Directors (the “ Board ”) of Interpace Biosciences, Inc. (the “ Company ”) appointed Christopher McCarthy, age 32, as Chief Financial Officer.
View on SEC.gov

INTERPACE BIOSCIENCES, INC. filing history →

Source: SEC EDGAR
accession 0001493152-23-026343
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.